your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com
Uptodate Reference Title
Screening questions to identify augmentation in patients on dopaminergic therapy for RLS[1]
Screening questions to identify augmentation in patients on dopaminergic therapy for RLS[1]
Do RLS symptoms appear earlier than when the drug was first started?
Are higher doses of the drug now needed, or do you need to take the drug earlier in the day to control symptoms?
Has the intensity of symptoms worsened since starting the drug?
Have symptoms spread to other body parts (eg, arms) since starting the drug?
RLS: restless legs syndrome.
Reference:
Garcia-Borreguero D, Silber MH, Winkelman JW, et al. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: A combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med 2016; 21:1.
